Latest Financials News

Albright Metals delivers strong high-grade gold results from its Golden Pike Project in Canada while boosting its balance sheet through a $1.8 million tenement sale to Catalyst Metals, sharpening its focus on high-impact assets.

Diamond Infraco 1 Pty Ltd, backed by IFM Global Infrastructure Fund, has tabled an all-cash takeover offer for the remaining Atlas Arteria securities at A$4.75, rising to A$5.10 if a 45% stake is secured. The bid comes amid concerns over Atlas Arteria’s recent strategic pivot and operational underperformance.

AML3D has maintained a steady $2.2 million quarterly revenue run rate and secured $12.5 million in new orders during 3Q26, pushing its total orders for FY2026 to $29 million. The company is aggressively expanding its US manufacturing footprint and making initial inroads into UK and European defence markets.

IperionX has transitioned its Virginia titanium operations to continuous 24/7 production, ramping proprietary HAMR™ titanium powder output to 4.2 metric tons in March and targeting 200 tons per annum by the end of 2026. Alongside manufacturing capacity expansions and strong U.S. Department of War backing, the company advances its critical minerals project in Tennessee.

Gale Pacific reported a $1.3 million operating cash outflow in Q3 FY26 amid Middle East geopolitical tensions but strengthened its net cash position by $18 million year-on-year. The company is executing a revised strategy focused on expanding its US commercial footprint and diversifying manufacturing beyond China.

Biome Australia has taken a significant step in its innovation journey by filing a patent for its next generation probiotic strain BMB18, with a clinical trial set to begin in Q4 FY26 in partnership with La Trobe University.

HITIQ Limited's March quarter saw a remarkable 223% jump in sales to $294k, driven by the nationwide rollout of its PROTEQT™ concussion management system and initial international sales. The company bolstered its governance and advisory ranks while managing funding to support its commercial push.

Alterity Therapeutics has secured FDA alignment on the chemistry and manufacturing controls for its ATH434 Phase 3 trial in Multiple System Atrophy, marking a pivotal regulatory milestone ahead of the planned mid-2026 End-of-Phase 2 meeting.

AdNeo (ASX:AD1) delivered its first positive operating cash flow quarter since its 2025 transformation, driven by strong revenue growth across all divisions and a growing $8m tender pipeline. The company advances its AI-first strategy while managing costs and acquisitions.

Sentinel Metals is poised to launch its maiden drilling campaign at the Columbia Gold-Silver Project in Montana, pending final regulatory approval. The company also bolsters its local engagement with a strategic executive hire and advances environmental studies.

Barton Gold Holdings has reported exceptional high-grade gold assays up to 170 g/t at its Challenger project and strong drilling progress at Tunkillia, underpinning an advancing feasibility study and a robust cash balance of $13.3 million.

88 Energy has amended its Participation Agreement with Burgundy Xploration, extending funding milestones to align with Burgundy’s US IPO process while securing US$400,000 in near-term payments and enhanced lease security. The Franklin Bluffs-1H well spud is now expected in Q1 2027, slightly delayed but underpinned by strong capital commitment.